Bioanalytical Testing Services Market - Global Forecasts to 2025

Table of Content

1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION & SCOPE 19
1.2.1 MARKETS COVERED 20
1.2.2 YEARS CONSIDERED FOR THE STUDY 20
1.3 CURRENCY 21
1.4 STAKEHOLDERS 21

2 RESEARCH METHODOLOGY 22
2.1 RESEARCH APPROACH 22
2.1.1 SECONDARY DATA 23
2.1.1.1 Key data from secondary sources 24
2.1.2 PRIMARY DATA 24
2.1.2.1 Key data from primary sources 25
2.1.2.2 Key industry insights 26
2.2 MARKET SIZE ESTIMATION 27
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 28
2.4 MARKET RANKING ANALYSIS 29
2.5 ASSUMPTIONS FOR THE STUDY 29

3 EXECUTIVE SUMMARY 30

4 PREMIUM INSIGHTS 33
4.1 BIOANALYTICAL TESTING SERVICES MARKET OVERVIEW 33
4.2 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET,
BY APPLICATION & COUNTRY (2019) 34
4.3 BIOANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 35
4.4 REGIONAL MIX: BIOANALYTICAL TESTING SERVICES MARKET 36
4.5 BIOANALYTICAL TESTING SERVICES MARKET: DEVELOPING VS.
DEVELOPED COUNTRIES 37

5 MARKET OVERVIEW 38
5.1 INTRODUCTION 38
5.2 MARKET DYNAMICS 38
5.2.1 DRIVERS 39
5.2.1.1 Rising focus on the analytical testing of biologics and biosimilars 39
5.2.1.2 Increasing preference for outsourcing analytical testing 39
5.2.1.3 Growing R&D expenditure in the pharmaceutical and biopharmaceutical industry 40
5.2.1.4 Rising adoption of the Quality by Design approach 42
5.2.2 RESTRAINTS 42
5.2.2.1 Dearth of skilled professionals 42
5.2.2.2 Pricing pressure faced by major players 42
5.2.3 OPPORTUNITIES 43
5.2.3.1 Emerging countries in the Asia Pacific region 43
5.2.3.2 Rising demand for specialized bioanalytical testing services 43
5.2.4 CHALLENGES 44
5.2.4.1 Innovative formulations demanding a unique
bioanalytical testing approach 44
5.2.4.2 Growing need to improve the sensitivity of bioanalytical methods 44

6 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 45
6.1 INTRODUCTION 46
6.2 CELL-BASED ASSAYS 46
6.2.1 BACTERIAL CELL-BASED ASSAYS 48
6.2.1.1 Bacterial cell-based assays segment to dominate the bioanalytical testing services market for cell-based assays 48
6.2.2 VIRAL CELL-BASED ASSAYS 49
6.2.2.1 Increasing outbreaks of viral diseases to support the growth of this market segment 49
6.3 VIROLOGY TESTING 50
6.3.1 IN VITRO VIROLOGY TESTING 51
6.3.1.1 Higher uptake of in vitro virology assays in the development of antiviral pharmaceuticals to drive the growth of this market segment 51
6.3.2 IN VIVO VIROLOGY TESTING 52
6.3.2.1 High utilization of in vivo assays during important production phases to drive their demand 52
6.3.3 SPECIES-SPECIFIC VIRAL PCR ASSAYS 53
6.3.3.1 Wide application of species-specific viral PCR assays in the detection of viral risks to support the growth of this market segment 53
6.4 METHOD DEVELOPMENT OPTIMIZATION AND VALIDATION 54
6.4.1 MANDATORY REQUIREMENT BY REGULATORY AUTHORITIES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 54
6.5 SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES 55
6.5.1 INCREASING APPLICATIONS OF SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 55
6.5.2 BACTERIAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES 57
6.5.3 VIRAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES 58
6.6 BIOMARKER TESTING 59
6.6.1 EMPHASIS ON THE DEVELOPMENT OF PERSONALIZED MEDICINE TO DRIVE THE DEMAND FOR BIOMARKER TESTING SERVICES 59
6.7 PHARMACOKINETIC TESTING 60
6.7.1 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE THE DEMAND FOR PHARMACOKINETIC TESTING SERVICES 60
6.8 OTHER SERVICES 61

7 BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION 62
7.1 INTRODUCTION 63
7.2 ONCOLOGY 64
7.2.1 ONCOLOGY IS THE LARGEST APPLICATION SEGMENT IN THE BIOANALYTICAL TESTING SERVICES MARKET 64
7.3 NEUROLOGY 65
7.3.1 ROBUST PIPELINE OF DRUGS FOR CNS DISEASES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 65
7.4 INFECTIOUS DISEASES 67
7.4.1 OUTBREAK OF COVID-19 TO BOOST THE GROWTH OF THIS MARKET SEGMENT 67
7.5 GASTROENTEROLOGY 68
7.5.1 RISING PREVALENCE OF CHRONIC DIGESTIVE DISORDERS TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT 68
7.6 CARDIOLOGY 69
7.6.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT 69
7.7 OTHER APPLICATIONS 71

8 BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 73
8.1 INTRODUCTION 74
8.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 74
8.2.1 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES ARE THE LARGEST END USERS OF BIOANALYTICAL TESTING SERVICES 74
8.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS 77
8.3.1 CDMOS PROVIDE SERVICES SUCH AS ANALYTICAL DEVELOPMENT, FORMULATION SCREENING AND DEVELOPMENT, STABILITY STUDIES, AND PRE-CLINICAL SAFETY ASSESSMENT STUDIES 77
8.4 CONTRACT RESEARCH ORGANIZATIONS 78
8.4.1 CONTRACT RESEARCH ORGANIZATIONS ARE INCREASINGLY SUBCONTRACTING THEIR ACTIVITIES TO NICHE LABORATORIES SPECIALIZED IN PROVIDING BIOANALYTICAL TESTING SERVICES 78

9 BIOANALYTICAL TESTING SERVICES MARKET, BY REGION 80
9.1 INTRODUCTION 81
9.2 NORTH AMERICA 82
9.2.1 US 86
9.2.1.1 US is the largest market for bioanalytical testing services in North America 86
9.2.2 CANADA 90
9.2.2.1 Increasing number of clinical trials in Canada to support market growth 90
9.3 EUROPE 93
9.3.1 GERMANY 97
9.3.1.1 Government support and flexible labor laws have made Germany a favorable location for clinical trials 97
9.3.2 FRANCE 99
9.3.2.1 High number of oncology clinical trials in France to drive market growth 99
9.3.3 UK 101
9.3.3.1 Investment by pharmaceutical sponsors in the UK for drug discovery services to support market growth 101
9.3.4 ITALY 104
9.3.4.1 Low drug approval time in Italy, along with the growing number of clinical trials, to drive market growth 104
9.3.5 SPAIN 107
9.3.5.1 Short study start-up times and rising R&D expenditure to boost the growth of the Spanish market 107
9.3.6 REST OF EUROPE 109
9.4 ASIA PACIFIC 112
9.4.1 CHINA 116
9.4.1.1 China is the largest market for bioanalytical testing services in the Asia Pacific 116
9.4.2 JAPAN 118
9.4.2.1 Rising geriatric population to drive market growth in Japan 118
9.4.3 INDIA 121
9.4.3.1 Growing pharmaceutical industry in India to drive market growth 121
9.4.4 REST OF ASIA PACIFIC 123
9.5 LATIN AMERICA 126
9.5.1 GROWING R&D EXPENDITURE IN THE PHARMACEUTICAL AND BIOPHARMACEUTICAL SECTOR TO DRIVE MARKET GROWTH IN LATIN AMERICA 126
9.6 MIDDLE EAST & AFRICA 128
9.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH IN THE MIDDLE EAST AND AFRICA 128

10 COMPETITIVE LANDSCAPE 131
10.1 INTRODUCTION 131
10.2 COMPETITIVE LEADERSHIP MAPPING 132
10.2.1 VISIONARY LEADERS 132
10.2.2 INNOVATORS 132
10.2.3 DYNAMIC DIFFERENTIATORS 132
10.2.4 EMERGING COMPANIES 132
10.3 BIOANALYTICAL TESTING SERVICES MARKET SHARE ANALYSIS 133
10.4 BIOANALYTICAL TESTING SERVICES MARKET: GEOGRAPHICAL ASSESSMENT 135
10.5 COMPETITIVE SITUATIONS & TRENDS 136
10.5.1 SERVICE LAUNCHES (2017–2020) 136
10.5.2 EXPANSIONS (2019–2020) 136
10.5.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2019–2020) 137
10.5.4 ACQUISITIONS (2019) 138
10.5.5 OTHER DEVELOPMENTS (2019) 138
11 COMPANY PROFILES 139
(Business Overview, Products Offered, Recent Developments, Strategic Overview, MnM View)*
11.1 CHARLES RIVER 139
11.2 MEDPACE 146
11.3 WUXI APPTEC 149
11.4 EUROFINS SCIENTIFIC 154
11.5 IQVIA INC. 159
11.6 SGS SA 163
11.7 LABORATORY CORPORATION OF AMERICA HOLDINGS 167
11.8 INTERTEK GROUP PLC 172
11.9 PRA HEALTH SCIENCES 174
11.10 SYNEOS HEALTH 177
11.11 ICON PLC 179
11.12 FRONTAGE LABS 182
11.13 PPD, INC. 185
11.14 PAREXEL INTERNATIONAL CORPORATION 188
11.15 ALMAC GROUP 190
11.16 CELERION 192
11.17 ALTASCIENCES 192
11.18 BIOAGILYTIX LABS 193
11.19 LOTUS LABS PVT. LTD. 193
11.20 LGC LIMITED 194
*Business Overview, Products Offered, Recent Developments, Strategic Overview, MnM View might not be captured in case of unlisted companies.
_
12 APPENDIX 196
12.1 DISCUSSION GUIDE 196
12.3 AVAILABLE CUSTOMIZATIONS 201
12.4 RELATED REPORTS 202
12.5 AUTHOR DETAILS 203

List of Figures

FIGURE 1 BIOANALYTICAL TESTING SERVICES MARKET SEGMENTATION 20
FIGURE 2 RESEARCH DESIGN 22
FIGURE 3 PRIMARY SOURCES 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 26
FIGURE 5 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS 27
FIGURE 6 DATA TRIANGULATION METHODOLOGY 28
FIGURE 7 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION) 30
FIGURE 8 BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION) 31
FIGURE 9 BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 31
FIGURE 10 BIOANALYTICAL TESTING SERVICES MARKET: REGIONAL SNAPSHOT 32
FIGURE 11 RISING FOCUS ON THE ANALYTICAL TESTING OF BIOLOGICS AND BIOSIMILARS TO DRIVE MARKET GROWTH 33
FIGURE 12 ONCOLOGY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC BIOANALYTICAL TESTING SERVICES MARKET IN 2019 34
FIGURE 13 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 35
FIGURE 14 NORTH AMERICA WILL CONTINUE TO DOMINATE THE BIOANALYTICAL TESTING SERVICES MARKET DURING THE FORECAST PERIOD 36
FIGURE 15 DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD 37
FIGURE 16 BIOANALYTICAL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
FIGURE 17 PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2017–2024 40
FIGURE 18 NUMBER OF REGISTERED STUDIES, 2001–2019 41
FIGURE 19 NUMBER OF PIPELINE DRUGS, BY COMPANY, 2019 41
FIGURE 20 GLOBAL NUMBER OF CLINICAL TRIALS IN DIFFERENT THERAPEUTIC AREAS 2015–2018 63
FIGURE 21 WORLDWIDE CANCER INCIDENCE AND MORTALITY (2018–2040) 64
FIGURE 22 ANNUAL DRUG APPROVALS BY CDER (2010–2019) 75
FIGURE 23 PHARMACEUTICAL R&D SPENDING, 2010–2018 75
FIGURE 24 ACTIVE PHARMACEUTICAL PIPELINE, 2001–2019 76
FIGURE 25 CHINA IS EXPECTED TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD 81
FIGURE 26 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA (2019) 82
FIGURE 27 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET SNAPSHOT 83
FIGURE 28 US: PIPELINE SPLIT OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES BY PHASE (JANUARY 2019) 87
FIGURE 29 TOTAL R&D EXPENDITURE OF THE US PHARMACEUTICAL INDUSTRY (2010–2018) 88
FIGURE 30 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET SNAPSHOT 94
FIGURE 31 UK: PHARMACEUTICAL R&D EXPENDITURE, 2013–2017 (USD BILLION) 102
FIGURE 32 UK: COMMERCIAL CLINICAL TRIAL APPLICATIONS, BY PHASE, 2013–2017 102
FIGURE 33 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET SNAPSHOT 113
FIGURE 34 KEY DEVELOPMENTS IN THE BIOANALYTICAL TESTING SERVICES MARKET 131
FIGURE 35 BIOANALYTICAL TESTING SERVICES MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019 133
FIGURE 36 MARKET SHARE ANALYSIS: BIOANALYTICAL TESTING SERVICES MARKET (2019) 134
FIGURE 37 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE BIOANALYTICAL TESTING SERVICES MARKET (2018) 135
FIGURE 38 CHARLES RIVER: COMPANY SNAPSHOT (2019) 139
FIGURE 39 MEDPACE: COMPANY SNAPSHOT (2018) 146
FIGURE 40 WUXI APPTEC: COMPANY SNAPSHOT (2018) 149
FIGURE 41 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019) 154
FIGURE 42 IQVIA INC.: COMPANY SNAPSHOT (2019) 159
FIGURE 43 SGS SA: COMPANY SNAPSHOT (2019) 163
FIGURE 44 LABORATORY CORPORATION OF AMERICA HOLDINGS:
COMPANY SNAPSHOT (2019) 167
FIGURE 45 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2019) 172
FIGURE 46 PRA HEALTH SCIENCES: COMPANY SNAPSHOT (2019) 174
FIGURE 47 SYNEOS HEALTH: COMPANY SNAPSHOT (2019) 177
FIGURE 48 ICON PLC: COMPANY SNAPSHOT (2019) 179
FIGURE 49 FRONTAGE LABS: COMPANY SNAPSHOT (2018) 182

List of Tables

TABLE 1 ANNUAL AVERAGE EXCHANGE RATES USED FOR CURRENCY
CONVERSIONS TO USD 21
TABLE 2 PATENT EXPIRY OF BEST-SELLING BIOLOGICS 39
TABLE 3 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 46
TABLE 4 BIOANALYTICAL TESTING SERVICES MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2018–2025 (USD MILLION) 47
TABLE 5 BIOANALYTICAL TESTING SERVICES MARKET FOR CELL-BASED ASSAYS BY COUNTRY, 2018–2025 (USD MILLION) 47
TABLE 6 BIOANALYTICAL TESTING SERVICES MARKET FOR BACTERIAL CELL-BASED ASSAYS, BY COUNTRY, 2018–2025 (USD MILLION) 48
TABLE 7 BIOANALYTICAL TESTING SERVICES MARKET FOR VIRAL CELL-BASED ASSAYS BY COUNTRY, 2018–2025 (USD MILLION) 49
TABLE 8 BIOANALYTICAL TESTING SERVICES MARKET FOR VIROLOGY TESTING BY TYPE, 2018–2025 (USD MILLION) 50
TABLE 9 BIOANALYTICAL TESTING SERVICES MARKET FOR VIROLOGY TESTING BY COUNTRY, 2018–2025 (USD MILLION) 50
TABLE 10 BIOANALYTICAL TESTING SERVICES MARKET FOR IN VITRO VIROLOGY TESTING BY COUNTRY, 2018–2025 (USD MILLION) 51
TABLE 11 BIOANALYTICAL TESTING SERVICES MARKET FOR IN VIVO VIROLOGY TESTING BY COUNTRY, 2018–2025 (USD MILLION) 52
TABLE 12 BIOANALYTICAL TESTING SERVICES MARKET FOR SPECIES-SPECIFIC VIRAL PCR ASSAYS, BY COUNTRY, 2018–2025 (USD MILLION) 53
TABLE 13 BIOANALYTICAL TESTING SERVICES MARKET FOR METHOD DEVELOPMENT OPTIMIZATION AND VALIDATION, BY COUNTRY, 2018–2025 (USD MILLION) 54
TABLE 14 BIOANALYTICAL TESTING SERVICES MARKET FOR SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES, BY COUNTRY, 2018–2025 (USD MILLION) 56
TABLE 15 BIOANALYTICAL TESTING SERVICES MARKET FOR BACTERIAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES, BY COUNTRY 2018–2025 (USD MILLION) 57
TABLE 16 BIOANALYTICAL TESTING SERVICES MARKET FOR VIRAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES, BY COUNTRY 2018–2025 (USD MILLION) 58
TABLE 17 BIOANALYTICAL TESTING SERVICES MARKET FOR BIOMARKER TESTING BY COUNTRY, 2018–2025 (USD MILLION) 59
TABLE 18 BIOANALYTICAL TESTING SERVICES MARKET FOR PHARMACOKINETIC TESTING BY COUNTRY, 2018–2025 (USD MILLION) 60
TABLE 19 BIOANALYTICAL TESTING SERVICES MARKET FOR OTHER SERVICES BY COUNTRY, 2018–2025 (USD MILLION) 61
TABLE 20 BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION 2018–2025 (USD MILLION) 64
TABLE 21 BIOANALYTICAL TESTING SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2018–2025 (USD MILLION) 65
TABLE 22 LIST OF PIPELINE DRUGS FOR NEUROLOGICAL DISORDERS (2018) 66
TABLE 23 BIOANALYTICAL TESTING SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2018–2025 (USD MILLION) 67
TABLE 24 BIOANALYTICAL TESTING SERVICES MARKET FOR INFECTIOUS DISEASES BY COUNTRY, 2018–2025 (USD MILLION) 68
TABLE 25 BIOANALYTICAL TESTING SERVICES MARKET FOR GASTROENTEROLOGY BY COUNTRY, 2018–2025 (USD MILLION) 69
TABLE 26 LIST OF PIPELINE DRUGS FOR CARDIOVASCULAR DISEASES (2018) 70
TABLE 27 BIOANALYTICAL TESTING SERVICES MARKET FOR CARDIOLOGY BY COUNTRY, 2018–2025 (USD MILLION) 71
TABLE 28 BIOANALYTICAL TESTING SERVICES MARKET FOR OTHER APPLICATIONS BY COUNTRY, 2018–2025 (USD MILLION) 72
TABLE 29 BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 2018–2025 (USD MILLION) 74
TABLE 30 BIOANALYTICAL TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 77
TABLE 31 BIOANALYTICAL TESTING SERVICES MARKET FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 78
TABLE 32 BIOANALYTICAL TESTING SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 79
TABLE 33 BIOANALYTICAL TESTING SERVICES MARKET, BY REGION 2018–2025 (USD MILLION) 82
TABLE 34 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET BY COUNTRY, 2018–2025 (USD MILLION) 84
TABLE 35 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 84
TABLE 36 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE 2018–2025 (USD MILLION) 84
TABLE 37 NORTH AMERICA: VIROLOGY TESTING MARKET, BY TYPE 2018–2025 (USD MILLION) 85
TABLE 38 NORTH AMERICA: SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 85
TABLE 39 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET BY APPLICATION, 2018–2025 (USD MILLION) 85
TABLE 40 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET BY END USER, 2018–2025 (USD MILLION) 86
TABLE 41 KEY INDICATORS: US 88
TABLE 42 US: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 89
TABLE 43 US: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 89
TABLE 44 US: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 89
TABLE 45 US: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION 2018–2025 (USD MILLION) 90
TABLE 46 US: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 2018–2025 (USD MILLION) 90
TABLE 47 KEY INDICATORS: CANADA 91
TABLE 48 NUMBER OF ACTIVE CLINICAL TRIALS IN CANADA, BY CONDITION (2019) 91
TABLE 49 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 92
TABLE 50 CANADA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 92
TABLE 51 CANADA: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 92
TABLE 52 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION 2018–2025 (USD MILLION) 93
TABLE 53 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 2018–2025 (USD MILLION) 93
TABLE 54 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY 2018–2025 (USD MILLION) 95
TABLE 55 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 95
TABLE 56 EUROPE: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 95
TABLE 57 EUROPE: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 96
TABLE 58 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION 2018–2025 (USD MILLION) 96
TABLE 59 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 2018–2025 (USD MILLION) 96
TABLE 60 KEY INDICATORS: GERMANY 97
TABLE 61 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 97
TABLE 62 GERMANY: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 98
TABLE 63 GERMANY: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 98
TABLE 64 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION 2018–2025 (USD MILLION) 98
TABLE 65 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 2018–2025 (USD MILLION) 99
TABLE 66 KEY INDICATORS: FRANCE 99
TABLE 67 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 100
TABLE 68 FRANCE: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 100
TABLE 69 FRANCE: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 100
TABLE 70 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION 2018–2025 (USD MILLION) 101
TABLE 71 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 2018–2025 (USD MILLION) 101
TABLE 72 KEY INDICATORS: UK 102
TABLE 73 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 103
TABLE 74 UK: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 103
TABLE 75 UK: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 103
TABLE 76 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION 2018–2025 (USD MILLION) 104
TABLE 77 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 2018–2025 (USD MILLION) 104
TABLE 78 KEY INDICATORS: ITALY 105
TABLE 79 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 105
TABLE 80 ITALY: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 105
TABLE 81 ITALY: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 106
TABLE 82 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION 2018–2025 (USD MILLION) 106
TABLE 83 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 2018–2025 (USD MILLION) 106
TABLE 84 KEY INDICATORS: SPAIN 107
TABLE 85 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 108
TABLE 86 SPAIN: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 108
TABLE 87 SPAIN: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 108
TABLE 88 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION 2018–2025 (USD MILLION) 109
TABLE 89 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 2018–2025 (USD MILLION) 109
TABLE 90 ROE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 110
TABLE 91 ROE: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 110
TABLE 92 ROE: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 111
TABLE 93 ROE: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION 2018–2025 (USD MILLION) 111
TABLE 94 ROE: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 2018–2025 (USD MILLION) 111
TABLE 95 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY 2018–2025 (USD MILLION) 114
TABLE 96 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 114
TABLE 97 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 114
TABLE 98 ASIA PACIFIC: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 115
TABLE 99 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 115
TABLE 100 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 2018–2025 (USD MILLION) 115
TABLE 101 KEY INDICATORS: CHINA 116
TABLE 102 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 117
TABLE 103 CHINA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 117
TABLE 104 CHINA: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 117
TABLE 105 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION 2018–2025 (USD MILLION) 118
TABLE 106 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 2018–2025 (USD MILLION) 118
TABLE 107 KEY INDICATORS: JAPAN 119
TABLE 108 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 119
TABLE 109 JAPAN: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 119
TABLE 110 JAPAN: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 120
TABLE 111 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION 2018–2025 (USD MILLION) 120
TABLE 112 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 2018–2025 (USD MILLION) 120
TABLE 113 INCREASE IN THE R&D EXPENDITURE OF THE TOP 5 INDIAN PHARMACEUTICAL COMPANIES (2010 VS. 2018) 121
TABLE 114 KEY INDICATORS: INDIA 121
TABLE 115 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 122
TABLE 116 INDIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 122
TABLE 117 INDIA: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 122
TABLE 118 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION 2018–2025 (USD MILLION) 123
TABLE 119 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 2018–2025 (USD MILLION) 123
TABLE 120 ROAPAC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 124
TABLE 121 ROAPAC: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 124
TABLE 122 ROAPAC: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 125
TABLE 123 ROAPAC: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION 2018–2025 (USD MILLION) 125
TABLE 124 ROAPAC: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 2018–2025 (USD MILLION) 125
TABLE 125 NUMBER OF CLINICAL TRIALS IN LATINA AMERICA, BY COUNTRY (JUNE 2019) 126
TABLE 126 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 127
TABLE 127 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE 2018–2025 (USD MILLION) 127
TABLE 128 LATIN AMERICA: VIROLOGY TESTING MARKET, BY TYPE 2018–2025 (USD MILLION) 127
TABLE 129 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 128
TABLE 130 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION) 128
TABLE 131 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 129
TABLE 132 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET, BY TYPE 2018–2025 (USD MILLION) 129
TABLE 133 MIDDLE EAST & AFRICA: VIROLOGY TESTING MARKET, BY TYPE 2018–2025 (USD MILLION) 130
TABLE 134 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET BY APPLICATION, 2018–2025 (USD MILLION) 130
TABLE 135 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET BY END USER, 2018–2025 (USD MILLION) 130